Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
51 /100
HIGH RISK
Score updated Aug 29, 2026

DMRA — Damora Therapeutics, Inc. Dilution Risk Tracker

Track DMRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMRA — Get alerts when the score changes →

As of August 29, 2026, Damora Therapeutics, Inc. (DMRA) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Damora Therapeutics, Inc. has a market capitalization of $1.53B, 61.74M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DMRA.
🔔 Track DMRA — Get forecast alerts →

Market Data

Market Cap$1.53B
Shares Outstanding61.74M
Float41.22M
Cash$576.50M
DebtN/A
Short InterestN/A

Institutional Holdings

91.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track DMRA for full holder detail →

Short Interest

Short Interest4.89M
Days to Cover11.7
% of Float11.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual DMRA Dilution Snapshot

Damora Therapeutics, Inc. (DMRA) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 29, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track DMRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,026+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DMRA
DMRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.